SUMMARY: The effects of the phosphatase inhibitors calyculin A and okadaic acid on amylase release from streptolysin-0 permeabilized rat pancreatic acini were investigated. Both agents induced similar biphasic effects with moderate potentiation of calcium-stimulated amylase release at medium and strong inhibition at higher concentrations. Calyculin A was thirty times more potent than okadaic acid and at 100 nM totally inhibited calcium-induced amylase release while 3pM okadaic acid reduced amylase release by 78%. 1OOnM calyculin A also completely inhibited GTPyS-potentiated amylase release and partially inhibited phorbol ester potentiated secretion. The data indicate that inhibition of a serine/threonine phosphatase, probably a type 1 phosphatase, leads to inhibition of calcium-induced amylase release in permeabilized pancreatic acini , 0 199~ Academic Press, Inc.
Regulated enzyme secretion by pancreatic acinar cells is physiologically induced by phospholipase C linked agonists such as cholecystokinin and carbachol. These agonists act on receptors belonging to the large family of seven transmembrane domain receptors which are coupled to heterotrimeric GTP-binding proteins (1). Receptor occupancy releases the alphasubunit of the G-protein which activates phospholipase C. Phospholipase C then cleaves phosphatidylinositol-4,!5bisphosphate into inositol 1,4,5 trisphosphate (IPs) and diacylglycerol (2,3). IP3 releases calcium from intracellular stores (4), while diacylglycerol stimulates protein kinase C (5). Calcium then can regulate several protein kinases and phosphatases present in acinar cells. Considerable evidence exists that changes in the phosphorylation of phosphoproteins are important for the regulation of secretion. Changes in the phosphorylation of several proteins in response to secretory agonists have been demonstrated in rodent pancreatic acinar cells (6, 7, 8) .
In order to gain more insight into the later steps of stimulus-secretion coupling we have developed a system of permeabilized acini using the bacterial pore forming toxin streptolysin-0 (9,lO). Similar systems have also been applied by others to a variety of cell types (11, 12) . The permeabilization allows introduction of compounds such as ions or peptides through pores in the plasma membrane into functionally intact cells in order to study their effects on secretion. Thus the early steps in stimulus-secretion coupling can be bypassed and the actions of intracellular messengers studied directly. As in most permeabilized secretory cells, digestive enzyme secretion by permeabilized rodent pancreatic acini is induced by calcium (9-11).
We have previously shown that inhibition of phosphatase activity by 3@I okadaic acid inhibits hormone-induced amylase release in intact acini and calcium-induced secretion in permeabilized acini (13). Okadaic acid inhibits purified serine/threonine phosphatases 2A, 1 and 28 with an IDso of 1.5 nM, 200nM and 4.5@I respectively (14,15) . Therefore these results indicated an effect of okadaic acid most likely on phosphatase type1 or 28. In the present study we investigated the effects of a different phosphatase inhibitor, calyculin A on amylase release by streptolysin-0 permeabilized rat pancreatic acini. Although its structure is distinct from okadaic acid, calyculin A inhibits serine/threonine phosphatase type 2A with similar potency as does okadaic acid but is 50 to 100 times more potent inhibitor of phosphatase type1 . Neither agent inhibits phosphotyrosine phosphatase activity (16, 17) .
MATERIAL AND METHODS
Chemicals: Streptolysin-0 was purchased from Wellcome Diagnostics (Greenville, NC); Calyculin A and okadaic acid from LC Services (Woburn, MA); chromatographically purified collagenase from Worthington Biochemical (Freehold, NJ); bovine serum albumin (fraction V) from ICN ImmunoBiologicals (Lisle, IL) and minimal essential amino acids from GIBCO (Grand Island, NY). 12-o-tetradecanoylphorbol-l3-acetate (TPA) and all other chemicals were obtained from Sigma Chemical (St. Louis, MO).
Preparation of pancreatic acini: Acini were prepared as previously described (6). Briefly, pancreata from white male Sprague Dawley rats were digested with purified collagenase and dispersed by pipetting through polypropylene pipettes of decreasing orifice, followed by filtration through a 150 pm nytex screen. Acini were purified by centrifugation through 4% bovine serum albumin (wt/vol) and then preincubated for 30 min at 370C in N-2-hydroxyethyl-piperazine-N-2-ethane-sulfonic acid (HEPES)-buffered Ringer solution (HR), pH 7.4, supplemented with 11.1 mM glucose, minimal Eagle's medium amino acids, 5 mg/ml bovine serum albumin, and 0.1 m@ml soybean trypsin inhibitor. Buffers were gassed with 100% 02. As preliminary experiments had shown that calyculin A and okadaic acid are much more potent in inhibiting amylase release when acini are pretreated for 30 min before stimulation, both agents were present during this preincubation in different concentrations according to the experimental design.
Permeabilization: After preincubation with the indicated amounts of phosphatase inhibitors, acini were pelleted and resuspended in piperazine-N,N'-bis(2-ethanesulfonicacid) (PIPES)-buffered potassium glutamate solution containing 20 mM PIPES (potassium salt, pH 7.0), 140 mM potassium glutamate, 1 mg/ml bovine serum albumin (BSA) and 0.1 mg/ml soybean trypsin inhibitor. 0.5 ml of acinar suspension was then added to 0.5 ml of the same solution containing phosphatase inhibitors, SLO, EGTA, and MgATP to yield final concentrations of 0.5 IU/ml SLO, 5 mM EGTA, 1 mM MgATP and the indicated concentrations of calyculin A and okadaic acid. The amount of Ca*+ and Mg*+ to be added to give final concentrations of 1 mM free Mg*+ and specified concentrations of free Ca*+ were calculated using a computer program as described earlier (6). Permeabilized acini were incubated for 20 min at 300C.
Amylase assay: After incubation samples were centrifuged for 10 see in an Eppendorf microcentrifuge. Amylase was detemined in the supernatant using procion yellow starch as substrate (18) . At the beginning of the incubation period a 1 ml aliquot of acinar suspension was centrifuged and amylase determined in the supernatant. This time 0 value was subtracted from the values obtained after incubation. The pellets were resuspended in water and sonic&d in order to determine total acinar amyiase content. Amy&e release during incubation was expressed as percentage of the total amylase content at the beginning of the incubation.
RESULTS
Effects of calyculin A on amylase release in permeabi/ized acini: Calyculin A at a concentration of 100 nM inhibited amylase release induced with a maximal dose of free calcium (1p.M). Basal release was unaffected (Fig 1) . It is interesting to note, however, that at 30 nM calyculin A there was no inhibition but rather a potentiation of calcium-induced secretion. Lower concentrations of Calyculin A had no effect on secretion. When okadaic acid was used, a similar concentration dependent biphasic curve was observed but the dose response was shifted to the right when compared to the effects of calyculin A. Thus calyculin A is 30 times more potent than okadaic acid in its effects on amylase release. In contrast to okadaic acid, calyculin A also inhibited amylase release completely while inhibition with okadaic acid was only 78%. Okadaic acid at concentrations above 3 ~.LM increases basal release (data not shown) which makes interpretation of its effects at these doses difficult. Both agents exhibited their full effects only after 30 min preincubation before permeabilization and stimulation of secretion with Ca 2+. Without any preincubation there was liffle effect on amylase release (data not shown).
Opposite effects of calyculin A et 30 end 100 nh4 on calcium-induced amyfase release: We then investigated the effect of 1 OOnM and 30nM calyculin A on a full calcium dose response of amylase release (Fig 2) . Secretion was stimulated by Ca2+ in a dose-dependent fashion; maximal release was observed at 1pM while secretion was inhibited at higher concentrations of free calcium. After 12 - 30 min preincubation 100 nM calyculin A completely inhibited calcium-induced secretion at all concentrations of calcium (Fig 2A) . The bottom panel shows that 30 nM calyculin A did not inhibit secretion but increased maximal amylase release by 28% (Fig 28) . This potentiation only occured at maximal doses of calcium but did not lead to a left shift of the calcium dose response curve. Basal release was not affected by either dose of calyculin A although the basal release in the set of experiments with or without 1OOnM calyculin A was higher than in the set of experiments with 30 nM calyculin.
Calyculin A tota/ly inhibits GTPyS-~fenfiafed and partial/y inhibits TPA-potentiated secretion:
GTPyS and phorbol esters such as TPA have been shown to potentiate calcium-stimulated amylase release by permeabilized acini (10,ll). We investigated the effects of calyculin A on phorbol ester and GTPyS-potentiated secretion (Fig 3) . Potentiation by both agents occured in a dose dependent manner with maximally effective doses of 30 @l GTPyS and 1 pM TPA respectively. The potentiation was strongest at 300 nM calcium where release was increased by 80-100% compared to calcium alone, while maximal release at 1 mM calcium was increased by only 30-40% (data not shown). Therefore the calcium concentration used for these experiments was 300 nM. Calyculin A completely inhibited the effect of GTPyS plus 300 nM calcium but only partially blocked the effect of TPA plus calcium (Fig 3) . 
DISCUSSION
In this study we have used the phosphatase inhibitors calyculin A and okadaic acid to investigate their effects on Ca*+-induced amylase release in permeabilized rat pancreatic acini. Both agents are believed to be specific for serinenhreonine phosphatases and have not been found to have an effect on tyrosine phosphatases or other kinases and phosphatases (14-l 7). Calyculin A at 1 OOnM totally inhibited secretion while okadaic acid at 3pM inhibited amylase release by 78%. It is interesting to note that both agents had a biphasic effect with moderate potentiation of calcium-induced release at medium doses (30nM and 300nM respectively). The reasons for this biphasic response are not clear but it indicates that these compounds have multiple effects on different phosphoproteins. Although there is no direct evidence which type of phosphatase is inhibited by calyculin A and okadaic acid, the higher potency of calyculin A suggests that inhibition of a phosphatase type 1 is the likely mechanism of action (15). However, to our knowledge calyculin A has not been tested for inhibition of the calcium dependent phosphatase 28 while okadaic acid inhibits this enzyme at micromolar concentrations (14).
One explanation for the inhibition of amylase release by both calyculin A and okadaic acid is that inhibition of serinenhreonine phosphatase activity shifts the steady state of phosphorylation of acinar phosphoproteins towards stronger phosphorylation as we have shown previously (13). This could then lead to inhibition of important steps in stimulus-secretion coupling. The fact that a 30 min preincubation before stimulation of secretion is necessary for both calyculin A and okadaic acid to fully inhibit amylase release supports that assumption. Alternatively, it could be assumed that a serine/threonine phosphatase mediated dephosphorylation plays an important role in stimulus-secretion coupling and that calyculin A and okadaic acid act through inhibition of this dephosphorylation to block secretion. The dephosphorylation of a 20 and 21.5 kDa phosphoprotein has been shown to correlate well with the onset of amylase secretion by mouse pancreatic acini (19). We have recently shown that okadaic acid inhibits hormone-induced amylase release in intact and calcium-induced amylase release in permeabilized rat pancreatic acini. Okadaic acid also strongly increased overall protein phosphorylation and inhibited the CCK-induced dephosphorylation of a 19 kDa phosphoprotein (13). If a dephosphorylation is important in stimulus-secretion coupling a calcium dependent phosphatase type 28 would seem to be a likely candidate as effector for a regulated dephosphorylation. In paramecium a calmoduliticalcineurin dependent dephosphorylation was shown to be important for secretion (20) .
As in other systems calcium dependent amylase release in streptolysin-0 permeabilized acini can be further potentiated by other agents such as GTP$ or phorbol esters (9,10,2122). In our experiments GTPyS showed an effect on amylase release only together with stimulatory concentrations of Ca2+ while at low free calcium, GTP$ has no effect (Fig 3, ref.10) . Similar results have been found by others (21, 24, 25) although there are reports indicating that GTPyS alone (26) or at a calcium concentration of as low as 10s M (11) can stimulate amylase release in streptolysin-0 permeabilized rat pancreatic acini. The reasons for these differences are unclear, The fact that Calyculin A completely blocks secretion induced by both calcium and GTPyS (Fig 3) indicates that GTPyS has its effect on the calcium mediated pathway in stimulus-secretion coupling and does not act independently.
Activation of protein kinase C with phorbol esters also potentiates calcium-induced amylase release although there is evidence that protein kinase C activation is not required for calcium dependent secretion to occur (22). There is also evidence that the effect of phorbol ester on secretion in acini may not be due to its effects on protein kinase C (27) . This might explain why neither calyculin A nor okadaic acid were able to fully inhibit secretion induced by both phorbol ester and calcium.
The present work clearly supports the importance of reversible protein phosphorylation in the regulation of secretion but further work is needed to identify both the phosphatases and the substrate proteins involved. Both calyculin A and okadaic acid will be useful tools in this endeavor. 
